GI Revive | Öflug meltingarblanda

1. Kim MH, Kim H. The roles of glutamine in the intestine and its implication in intestinal diseases. Int J Mol Sci. 2017;18(5):1051. doi:10.3390/ijms18051051

2. Perna S, Alalwan TA, Alaali Z, et al. The role of glutamine in the complex interaction between gut microbiota and health: a narrative review. Int J Mol Sci. 2019;20(20):5232. doi:10.3390/ijms20205232

3. Zhou Q, Verne ML, Fields JZ, et al. Randomised placebo‑controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019;68(6):996‑1002. doi:10.1136/gutjnl‑2017‑315136

4. de Oliveira Santos R, da Silva Cardoso G, da Costa Lima L, et al. L‑glutamine and physical exercise prevent intestinal inflammation and oxidative stress without improving gastric dysmotility in rats with ulcerative colitis. Inflammation. 2021;44(2):617‑632. doi:10.1007/s10753‑020‑01361‑3

5. Salvatore S, Heuschkel R, Tomlin S, et al. A pilot study of N‑acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14(12):1567‑1579. doi:10.1046/j.1365‑2036.2000.00883.x

6. Chen J, Shen C, Liu C. N‑acetylglucosamine: production and applications. Mar Drugs. 2010;8(9)2493‑2516. doi:10.3390/md8092493

7. Abo H, Muraki A, Harusato A, et al. N‑acetylglucosamine‑6‑O sulfation on intestinal mucins prevents obesity and intestinal inflammation by regulating gut microbiota. JCI Insight. 2023;8(16):e165944. doi:10.1172/jci.insight.165944

8. Aleman RS, Paz D, Cedillos R, Tabora M, Olson DW, Aryana K. Attributes of culture bacteria as influenced by ingredients that help treat leaky gut. Microorganisms. 2023;11(4):893. doi:10.3390/microorganisms11040893

9. Choi SI, Shin YC, Lee JS, Yoon YC, Kim JM, Sung MK. N‑acetylglucosamine and its dimer ameliorate inflammation in murine colitis by strengthening the gut barrier function. Food Funct. 2023;14(18):8533‑8544. doi:10.1039/d3fo00282a

10. Qu D, Wang G, Yu L, Tian F, Chen W, Zhai Q. The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation. Carbohydr Polym. 2021;258:117651. doi:10.1016/j.carbpol.2021.117651

11. Sicard JF, Vogeleer P, Le Bihan G, et al. N‑acetyl‑glucosamine influences the biofilm formation of Escherichia coli. Gut Pathog. 2018;10:26. doi:10.1186/s13099‑018‑0252‑y

12. Zhu AZX, Patel I, Hidalgo MP, Gandhi V. N‑acetylglucosamine for treatment of inflammatory bowel disease: a real‑world pragmatic clinical trial. Nat Med J. 2015;7(4). https://www.naturalmedicinejournal.com/journal/n‑acetylglucosamine‑treatment‑inflammatory‑bowel‑disease

13. Dias AM, Correia A, Pereira MS, et al. Metabolic control of T cell immune response through glycans in inflammatory bowel disease. Proc Natl Acad Sci U S A. 2018;115(20):E4651‑E4660. doi:10.1073/pnas.1720409115

14. Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochim Biophys Acta. 2015;1850(1):236‑252. doi:10.1016/j.bbagen.2014.05.003

15. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep. 2010;12(5):319‑330. doi:10.1007/s11894‑010‑0131‑2

16. Chang YH, Weng CL, Lin KI. O‑GlcNAcylation and its role in the immune system. J Biomed Sci. 2020;27(1):57. doi:10.1186/s12929‑020‑00648‑9

17. Hu X, Sun X, Zhao Y, et al. GlcNac produced by the gut microbiome enhances host influenza resistance by modulating NK cells. Gut Microbes. 15(2):2271620. doi:10.1080/19490976.2023.2271620

18. Machacek M, Slawson C, Fields PE. O‑GlcNAc: a novel regulator of immunometabolism. J Bioenerg Biomembr. 2018;50(3):223‑229. doi:10.1007/s10863‑018‑9744‑1

19. Grigorian A, Araujo L, Nandita NN, Place DJ, Choudhury B, Demetriou M. N‑acetylglucosamine inhibits T‑helper 1 (Th1)/T‑helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis. J Biol Chem. 2011;286(46):40133‑40141. doi:10.1074/jbc.M111.277814

20. Sy M, Newton BL, Pawling J, et al. N‑acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial. J Neuroinflammation. 2023;20(1):209. doi:10.1186/s12974‑023‑02893‑9

21. Richter J, Capková K, Hříbalová V, et al. Collagen‑induced arthritis: severity and immune response attenuation using multivalent N‑acetyl glucosamine. Clin Exp Immunol. 2014;177(1):121‑133. doi:10.1111/cei.12313

22. Hewlings S, Kalman D. A review of zinc‑L‑carnosine and its positive effects on oral mucositis, taste disorders, and gastrointestinal disorders. Nutrients. 2020;12(3):665. doi:10.3390/nu12030665

23. Mahmood A, FitzGerald AJ, Marchbank T, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. 2007;56(2):168‑175. doi:10.1136/gut.2006.099929

24. Efthymakis K, Neri M. The role of zinc L‑carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clin Res Hepatol Gastroenterol. 2022;46(7):101954. doi:10.1016/j.clinre.2022.101954

25. Shaik Y, Caraffa A, Ronconi G, Lessiani G, Conti P. Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin. Cent Eur J Immunol. 2018;43(4):476‑481. doi:10.5114/ceji.2018.81347

26. Kim JE, Lee MR, Park JJ, et al. Quercetin promotes gastrointestinal motility and mucin secretion in loperamide‑induced constipation of SD rats through regulation of the mAChRs downstream signal. Pharm Biol. 2018;56(1):309‑317. doi:10.1080/13880209.2018.1474932

27. Butawan M, Benjamin R, Bloomer R. Methylsulfonylmethane: applications and safety of a novel dietary supplement. Nutrients. 2017;9(3):290. doi:10.3390/nu9030290

28. Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti‑inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2016;55(1):5. doi:10.1080/13880209.2016.1225775

29. Peterson CT, Sharma V, Uchitel S, et al. Prebiotic potential of herbal medicines used in digestive health and disease. J Altern Complement Med. 2018;24(7):656. doi:10.1089/acm.2017.0422

30. Ahluwalia B, Magnusson MK, Böhn L, et al. Randomized clinical trial: effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2020;32(8):e13860. doi:10.1111/nmo.13860

31. Deters A, Zippel J, Hellenbrand N, Pappai D, Possemeyer C, Hensel A. Aqueous extracts and polysaccharides from marshmallow roots (Althea officinalis L.): cellular internalisation and stimulation of cell physiology of human epithelial cells in vitro. J Ethnopharmacol. 2010;127(1):62‑69. doi:10.1016/j.jep.2009.09.050

32. Miraj S, Alesaeidi S. A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile). Electron Physician. 2016;8(9):3024. doi:10.19082/3024

33. Ortaç D, Cemek M, Karaca T, et al. In vivo anti‑ulcerogenic effect of okra (Abelmoschus esculentus) on ethanol‑induced acute gastric mucosal lesions. Pharm Biol. 2018;56(1):165. doi:10.1080/13880209.2018.1442481

34. Murray MT. Glycyrrhiza glabra (licorice). In: Pizzorno JE, Murray MT, eds. Textbook of Natural Medicine. 5th ed. Churchill Livingstone; 2020:641‑647.e3. doi:10.1016/B978‑0‑323‑43044‑9.00085‑6

35. Raveendra KR, Jayachandra, Srinivasa V, et al. An extract of Glycyrrhiza glabra (GutGard) alleviates symptoms of functional dyspepsia: a randomized, double‑blind, placebo‑controlled study. Evid Based Complement Altern Med. 2011;2012:216970. doi:10.1155/2012/216970

36. Puram S, Suh HC, Kim SU, et al. Effect of GutGard in the management of Helicobacter pylori: a randomized double blind placebo controlled study. Evid Based Complement Altern Med. 2013;2013:263805. doi:10.1155/2013/263805

37. Zaghlool SS, Shehata BA, Abo‑Seif AA, El‑Latif HAA. Protective effects of ginger and marshmallow extracts on indomethacin‑induced peptic ulcer in rats. J Nat Sci Biol Med. 2015;6(2):421. doi:10.4103/0976‑9668.160026

38. Jabri MA, Aissani N, Tounsi H, Sakly M, Marzouki L, Sebai H. Protective effect of chamomile (Matricaria recutita L.) decoction extract against alcohol‑induced injury in rat gastric mucosa. Pathophysiology. 2017;24(1):1‑8. doi:10.1016/j.pathophys.2016.11.001

39. Sah A, Naseef PP, Kuruniyan MS, Jain GK, Zakir F, Aggarwal G. A comprehensive study of therapeutic applications of chamomile. Pharmaceuticals. 2022;15(10):1284. doi:10.3390/ph15101284

40. Malek Mahdavi A, Javadivala Z, Ahmadian E. Effects of okra (Abelmoschus esculentus L) on inflammatory mediators: a systematic review of preclinical studies. Food Funct. 2022;13(6):3159‑3169. doi:10.1039/d1fo03915f

41. Wu J, Cao M, Hu M, et al. Intervention effects of okra extract on brain‑gut peptides and intestinal microorganisms in sleep deprivation rats. Evid Based Complement Altern Med. 2022;2022:9855411. doi:10.1155/2022/9855411

42. Messing J, Thöle C, Niehues M, et al. Antiadhesive properties of Abelmoschus esculentus (okra) immature fruit extract against Helicobacter pylori adhesion. PLoS One. 2014;9(1):e84836. doi:10.1371/journal.pone.0084836

43. Khan S, Rafi Z, Baker A, et al. Phytochemical screening, nutritional value, anti‑diabetic, anti‑cancer, and anti‑bacterial assessment of aqueous extract from Abelmoschus esculentus pods. Processes. 2022;10(2):183. doi:10.3390/pr10020183

44. Jana UK, Kango N, Pletschke B. Hemicellulose‑derived oligosaccharides: emerging prebiotics in disease alleviation. Front Nutr. 2021;8:670817. doi:10.3389/fnut.2021.670817

45. Tang R, Li L. Modulation of short‑chain fatty acids as potential therapy method for type 2 diabetes mellitus. Can J Infect Dis Med Microbiol. 2021;2021:6632266. doi:10.1155/2021/6632266

46. Wu Y, Chen Y, Lu Y, Hao H, Liu J, Huang R. Structural features, interaction with the gut microbiota and anti‑tumor activity of oligosaccharides. RSC Adv. 2020;10(28):16339‑16348. doi:10.1039/D0RA00344A

47. Hu H, Zhang S, Pan S. Characterization of citrus pectin oligosaccharides and their microbial metabolites as modulators of immunometabolism on macrophages. J Agric Food Chem. 2021;69(30):8403‑8414. doi:10.1021/acs.jafc.1c01445

48. Koyama T, Nagata N, Nishiura K, Miura N, Kawai T, Yamamoto H. Prune juice containing sorbitol, pectin, and polyphenol ameliorates subjective complaints and hard feces while normalizing stool in chronic constipation: a randomized placebo‑controlled trial. Am J Gastroenterol. 2022;117(10):1714‑1717. doi:10.14309/ajg.0000000000001931

49. Lever E, Scott SM, Louis P, Emery PW, Whelan K. The effect of prunes on stool output, gut transit time and gastrointestinal microbiota: a randomised controlled trial. Clin Nutr. 2019;38(1):165‑173. doi:10.1016/j.clnu.2018.01.003

50. Simpson AMR, De Souza MJ, Damani J, et al. Prune supplementation for 12 months alters the gut microbiome in postmenopausal women. Food Funct. 2022;13(23):12316‑12329. doi:10.1039/d2fo02273g

51. Stacewicz‑Sapuntzakis M, Bowen PE, Hussain EA, Damayanti‑Wood BI, Farnsworth NR. Chemical composition and potential health effects of prunes: a functional food? Crit Rev Food Sci Nutr. 2001;41(4):251‑286. doi:10.1080/20014091091814